Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Extravasation of Cytotoxic Agents

Compendium for Prevention and Management
Media-Kombination
XIII, 392 Seiten
2009 | 2nd ed. 2010
Springer Wien
978-3-211-88889-6 (ISBN)

Lese- und Medienproben

Extravasation of Cytotoxic Agents - Ines Mader, Patrizia R. Fürst-Weger, Robert M. Mader, Elisabeth Nogler-Semenitz, Sabine Wassertheurer
CHF 149,75 inkl. MwSt
  • Versand in 10-14 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken

The extravasation of cytotoxic agents can result in severe local tissue damage and medical emergencies during tumour therapy. This revised compendium is intended to help clinicians assess any situation speedily and with certainty. The general section of the book includes topics such as predisposition, prevention, type of harm, general measures in handling extravasated drugs, specific antidotes, and documentation. In the 2nd edition, the scientific information contained in the general section and relating to the actual substances has been updated. The substance specific part of the book includes detailed instructions on handling more than 50 cytotoxic drugs, to initiate targeted measures. Templates for an extravasation set, overview tables, documentation sheets, and patient information, as we as a CD-ROM are included to support clinical practice. The book is the outcome of a consensus of an interdisciplinary working group that has collected and systematically reviewed all published literature on the topic.

Problem outline.- Problem outline.- General part.- and definitions.- Predisposition and prevention.- Clinical practice.- Measures.- Aftercare.- Documentation.- Forming clinical working groups.- Quality control and quality assurance.- Open questions and outlook.- Substance-specific part.- Remarks on the substance-specific part.- Amsacrine.- L-Asparaginase.- Bendamustine.- Bleomycin.- Bortezomib.- Busulfan.- Carboplatin.- Carmustine.- Cisplatin.- Cladribine.- Cyclophosphamide.- Cytarabine.- Dacarbazine.- Dactinomycin.- Daunorubicin.- Daunorubicin liposomal.- Docetaxel.- Doxorubicin.- Doxorubicin liposomal, Doxorubicin pegylated liposomal.- Epirubicin.- Estramustine.- Etoposide.- Etoposide phosphate.- Fludarabine.- 5-Fluorouracil.- Fotemustine.- Gemcitabine.- Idarubicin.- Ifosfamide.- Irinotecan.- Melphalan.- Methotrexate.- Mitomycin C.- Mitoxantrone.- Nimustine.- Oxaliplatin.- Paclitaxel.- Pegaspargase.- Pemetrexed.- Pentostatin.- Raltitrexed.- Streptozocin.- Teniposide.- Thiotepa.- Topotecan.- Treosulfan.- Trimetrexate.- Vinblastine.- Vincristine.- Vindesine.- Vinorelbine.

Erscheint lt. Verlag 26.10.2009
Übersetzer Birte Twisselmann
Zusatzinfo XIII, 392 p. With CD-ROM.
Verlagsort Vienna
Sprache englisch
Maße 155 x 235 mm
Gewicht 870 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Schlagworte Chemotherapy • complication • cytotoxic agents • documentation • extrvasation • Hematology • necrosis • Oncology • prevention • risk factor • Tumor • Zelle (biolog.) • Zelle (Biologie)
ISBN-10 3-211-88889-6 / 3211888896
ISBN-13 978-3-211-88889-6 / 9783211888896
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich